Home > News > featured news > NextGen Healthcare Expands Relationship with InstaMed to Simplify Payment Processing for Patients and Providers

Health Technology

NextGen Healthcare Expands Relationship with InstaMed to Simplify Payment Processing for Patients and Providers

NextGen Healthcare, Inc. | July 19, 2022 | Read time : 32:46 min

NextGen Healthcare

NextGen Healthcare, Inc, a leading provider of innovative, cloud-based healthcare technology solutions,  announced that it has expanded its long-term relationship with InstaMed, a J.P. Morgan company, in a deal that modernizes payment processing through NextGen® Pay powered by InstaMed. This solution expands payment options and convenience for patients, who can pay online when visiting providers that utilize the NextGen® Practice Management solution. The platform also enables healthcare practices to automate collections and manage and view payments all in one system. The payment solution is not only convenient but secure, utilizing best-in-class data encryption protections.

“With NextGen Pay powered by InstaMed, we’re taking the friction out of the patient-provider payment experience. Patients want a simple and streamlined process for paying their medical bills; providers want to focus on delivering the best care possible without being mired in collection inefficiencies. Our integrated solution delivers on both needs.”

 Srinivas (Sri) Velamoor, chief growth and strategy officer for NextGen Healthcare

InstaMed is an industry leader in collecting healthcare payments throughout the patient journey. A recent trends report published by InstaMed highlights the importance of payment convenience to patients. According to the survey, 83% of patients want to continue using virtual and self-service options for care post-pandemic. Another 74% prefer online payment for medical bills. Additionally, 74% of millennials would switch providers for a better healthcare payment experience.

“The expansion of our work with NextGen Healthcare is the evolution of our longstanding relationship rooted in delivering better healthcare payment experiences for both providers and patients,” said Jon Neal, head of business development at InstaMed and managing director at J.P.Morgan. “The demand and need for digital, automated and simple payment processes have never been higher. We are excited to see our solution drive real change for providers and patients.”

Several NextGen Healthcare clients are already benefiting from NextGen Pay powered by InstaMed, which allows patients the convenience of saving credit card information within the online portal for quick payments on the go. With the expanded relationship, patients will also have the option to use Apple Pay® mobile payment solutions or Google Pay™ payment services at in-person care visits.

“Now, our practice is a one-stop shop for patient collections,” said Matthew Pierre, chief executive officer of Loden Vision Centers, a NextGen Healthcare client based in Nashville. “The billing department can manage, view and collect payments all in one place. NextGen Pay powered by InstaMed improves the entire payment process, start to finish.”

A webinar titled Trends in Healthcare Payments Annual Report: A Roadmap to the Future, set for July 21 at 2 p.m. EST, will delve into survey results and trends. Click here to register.

About NextGen Healthcare, Inc.
NextGen Healthcare, Inc. is a leading provider of innovative healthcare technology solutions. We are reimagining ambulatory healthcare with award-winning solutions that enable high-performing practices to create healthier communities. We partner with medical, behavioral and dental providers in their journey toward whole person health and value-based care. Our highly integrated, intelligent and interoperable solutions go beyond EHR and Practice Management to increase clinical quality and productivity, enrich the patient experience and drive superior financial performance. We are on a quest to achieve better healthcare outcomes for all. 

About InstaMed
InstaMed, a J.P. Morgan company, is part of the firm’s Healthcare Payments business that supports clients across the Corporate and Investment Bank, Commercial Bank and Chase Business Bank. J.P. Morgan Healthcare Payments has integrated InstaMed’s solutions to deliver an end-to-end suite of payments, treasury, and banking solutions to healthcare organizations of all sizes. InstaMed powers a better healthcare payments experience and connects consumers, providers and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, processing payments and moving healthcare data seamlessly, and improving consumer satisfaction. Consumers, providers and payers benefit from InstaMed’s exclusive focus on healthcare, integration into any healthcare IT system, robust analytics and proven scale.

Spotlight

Graft-Versus-Host Disease Prevention

Watch to see how changes in technology are helping to prevent graft-versus-host disease in cancer patients who receive bone marrow or stem cell transplants.

More featured news

Spotlight

Graft-Versus-Host Disease Prevention

Watch to see how changes in technology are helping to prevent graft-versus-host disease in cancer patients who receive bone marrow or stem cell transplants.

Related News

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology

Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias

PRNewswire | July 25, 2023

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter, with small electrodes arranged in a fixed array formation to provide high-definition electrophysiological mapping of complex cardiac arrhythmia cases like persistent atrial fibrillation (AFib), redo AFib ablation, atrial tachycardia, and ventricular tachycardia. Cardiac arrhythmias are a growing epidemic. AFib is the most common type of cardiac arrhythmia and impacts nearly 40 million people worldwide, with up to 6 million of these individuals living in the U.S.1,2 AFib is a progressive disease, and if left untreated can get worse over time or lead to other serious complications like heart disease or stroke.3,4 Catheter ablation is a safe and effective procedure to restore the heart's incorrect electrical signals, which causes an abnormal heart rhythm.5 This new catheter includes 48 electrodes symmetrically distributed across and along six splines and combines with the CARTO® 3 System to deliver intelligent insights and high-resolution directional mapping.6 Additionally, the OPTRELL™ Mapping Catheter has tight electrode spacing and small electrodes, which produce higher signal resolution, resulting in enhanced maps of the heart.7,8 With these high-definition maps, clinicians have a better understanding of where the arrhythmia is occurring and can develop a more effective ablation strategy. "The OPTRELL™ Mapping Catheter has a fixed electrode array structure that provides greater diagnostic insight, which allows physicians to quickly and effectively identify ablation targets," said Pasquale Santangeli, M.D., Ph.D., Cardiovascular Medicine, Cleveland Clinic Main Campus.ii "This catheter and the Local Conduction Vectors give me the confidence to quickly and effectively detect ablation lesion gaps and the arrhythmia substrate, even in the most complex cases, including persistent AFib, redo AFib ablation, atrial tachycardia, and ventricular tachycardia." The OPTRELL™ Mapping Catheter is powered by the CARTO® 3 System, which offers Local Conduction Vectors that display the real-time direction and speed of the electrical impulses traveling through the heart.9 With these Local Conduction Vectors, clinicians gain enhanced understanding of complex circuits and mechanisms and can confidently detect gaps in ablation lesions.7 Together, these technologies can help clinicians quickly identify areas that need ablation and apply more effective therapy in a shorter time. "The OPTRELL™ Mapping Catheter rounds out the Biosense Webster diagnostic mapping portfolio, providing physicians with a comprehensive set of tools, integrated with our CARTO® 3 mapping system, to diagnose and treat arrhythmias," said Jasmina Brooks, President, Biosense Webster, Inc. "This is the latest example of the continued commitment of Biosense Webster to providing clinicians with innovative tools to improve efficiency and effectiveness of procedures and quality of care for patients." The OPTRELL™ Mapping Catheter with TRUEref™ Technology received U.S. Food and Drug Administration (FDA) 510(k) clearance in 2022 and is now available in the U.S. The OPTRELL™ Mapping Catheter with TRUEref™ Technology will be commercially available in Japan later this year. About Biosense Webster Biosense Webster, Inc. is the global market leader in the science and technology behind the diagnosis and treatment of cardiac arrhythmias. Part of Johnson & Johnson MedTech, the specialized medical-technology company is headquartered in Irvine, California, and works across the world to advance the tools and solutions that help electrophysiologists identify, treat, and deliver care. About Johnson & Johnson MedTechi At Johnson & Johnson MedTech,i we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.

Read More

Healthcare Analytics

Press Ganey and Ardent Health Services Announce Partnership to Improve the Human Experience in Healthcare and Move the Needle Toward Zero Harm

businesswire | August 24, 2023

Press Ganey, the renowned leader in transforming the Human Experience (HX) across the healthcare ecosystem of patient, employee, member, and consumer journeys, announced a strategic partnership with Ardent Health Services, a leading healthcare provider with 30 hospitals, more than 200 sites of care and 1,400 aligned providers across six states. The two organizations aim to redefine the Human Experience of healthcare and accelerate the drive toward zero harm. Bolstered by a shared commitment to safety, quality, and patient experience, the partnership leverages Press Ganey's Human Experience platform to pioneer advancements across the continuum of care. Ardent’s relationship with Press Ganey underscores their shared vision for a safer, more human-focused era of healthcare. Through this collaboration, Ardent will harness Press Ganey's industry-leading Human Experience platform, fostering a proactive and holistic approach to healthcare excellence and innovation. “Ardent’s partnership with Press Ganey aligns with our commitment to caring for others and a culture of safety through our MissionZERO initiative,” said Marty Bonick, President and CEO of Ardent. “As part of our journey to become a highly reliable organization, we hold ourselves to the highest standard of patient care and recognize Press Ganey as a true partner in this endeavor. Together, we understand that the people we serve are at the center of all we do. That is the Human Experience." Press Ganey's approach to patient experience and safety aligns seamlessly with Ardent's commitment to innovation and its MissionZERO imperative. Through the partnership, both organizations will push the envelope of healthcare transformation, leading the charge toward a future marked by exceptional patient outcomes and a culture of high reliability. "We are honored to stand side by side with Ardent in their unwavering resolve to achieve MissionZERO. Our mutual dedication to advancing the Human Experience in healthcare is a powerful catalyst for positive transformation," said Patrick T. Ryan, Chairman and CEO of Press Ganey. "This partnership reinforces our firm belief that every patient deserves the highest level of care and safety, and an experience defined by compassion." About Press Ganey Press Ganey, the leading Human Experience (HX) healthcare performance improvement company, offers an integrated suite of solutions that address safety, clinical excellence, patient and member experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality, and experience of care. Press Ganey is a PG Forsta company. About PG Forsta PG Forsta provides the technology and expertise to help organizations get a deeper, more complete understanding of the experiences of their audiences. The company powers the HX (Human Experience) Platform—a comprehensive experience and research technology platform that breaks down the silos between CX (Customer Experience), Employee Experience (EX), Patient Experience (PX), and Market Research. PG Forsta serves a variety of industries, including healthcare, financial services, hospitality, market research, professional services, retail, and technology. About Ardent Health Services Ardent Health Services is a leading provider of healthcare in communities across the country. With a focus on consumer-friendly processes and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent owns and operates 30 hospitals and 200+ sites of care with more than 1,400 aligned providers in six states. From newly constructed healthcare facilities and expanded services to lifesaving technology and outstanding opportunities for team members, Ardent is committed to providing the resources communities need to keep high quality healthcare close to home.

Read More

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology

Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias

PRNewswire | July 25, 2023

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter, with small electrodes arranged in a fixed array formation to provide high-definition electrophysiological mapping of complex cardiac arrhythmia cases like persistent atrial fibrillation (AFib), redo AFib ablation, atrial tachycardia, and ventricular tachycardia. Cardiac arrhythmias are a growing epidemic. AFib is the most common type of cardiac arrhythmia and impacts nearly 40 million people worldwide, with up to 6 million of these individuals living in the U.S.1,2 AFib is a progressive disease, and if left untreated can get worse over time or lead to other serious complications like heart disease or stroke.3,4 Catheter ablation is a safe and effective procedure to restore the heart's incorrect electrical signals, which causes an abnormal heart rhythm.5 This new catheter includes 48 electrodes symmetrically distributed across and along six splines and combines with the CARTO® 3 System to deliver intelligent insights and high-resolution directional mapping.6 Additionally, the OPTRELL™ Mapping Catheter has tight electrode spacing and small electrodes, which produce higher signal resolution, resulting in enhanced maps of the heart.7,8 With these high-definition maps, clinicians have a better understanding of where the arrhythmia is occurring and can develop a more effective ablation strategy. "The OPTRELL™ Mapping Catheter has a fixed electrode array structure that provides greater diagnostic insight, which allows physicians to quickly and effectively identify ablation targets," said Pasquale Santangeli, M.D., Ph.D., Cardiovascular Medicine, Cleveland Clinic Main Campus.ii "This catheter and the Local Conduction Vectors give me the confidence to quickly and effectively detect ablation lesion gaps and the arrhythmia substrate, even in the most complex cases, including persistent AFib, redo AFib ablation, atrial tachycardia, and ventricular tachycardia." The OPTRELL™ Mapping Catheter is powered by the CARTO® 3 System, which offers Local Conduction Vectors that display the real-time direction and speed of the electrical impulses traveling through the heart.9 With these Local Conduction Vectors, clinicians gain enhanced understanding of complex circuits and mechanisms and can confidently detect gaps in ablation lesions.7 Together, these technologies can help clinicians quickly identify areas that need ablation and apply more effective therapy in a shorter time. "The OPTRELL™ Mapping Catheter rounds out the Biosense Webster diagnostic mapping portfolio, providing physicians with a comprehensive set of tools, integrated with our CARTO® 3 mapping system, to diagnose and treat arrhythmias," said Jasmina Brooks, President, Biosense Webster, Inc. "This is the latest example of the continued commitment of Biosense Webster to providing clinicians with innovative tools to improve efficiency and effectiveness of procedures and quality of care for patients." The OPTRELL™ Mapping Catheter with TRUEref™ Technology received U.S. Food and Drug Administration (FDA) 510(k) clearance in 2022 and is now available in the U.S. The OPTRELL™ Mapping Catheter with TRUEref™ Technology will be commercially available in Japan later this year. About Biosense Webster Biosense Webster, Inc. is the global market leader in the science and technology behind the diagnosis and treatment of cardiac arrhythmias. Part of Johnson & Johnson MedTech, the specialized medical-technology company is headquartered in Irvine, California, and works across the world to advance the tools and solutions that help electrophysiologists identify, treat, and deliver care. About Johnson & Johnson MedTechi At Johnson & Johnson MedTech,i we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.

Read More

Healthcare Analytics

Press Ganey and Ardent Health Services Announce Partnership to Improve the Human Experience in Healthcare and Move the Needle Toward Zero Harm

businesswire | August 24, 2023

Press Ganey, the renowned leader in transforming the Human Experience (HX) across the healthcare ecosystem of patient, employee, member, and consumer journeys, announced a strategic partnership with Ardent Health Services, a leading healthcare provider with 30 hospitals, more than 200 sites of care and 1,400 aligned providers across six states. The two organizations aim to redefine the Human Experience of healthcare and accelerate the drive toward zero harm. Bolstered by a shared commitment to safety, quality, and patient experience, the partnership leverages Press Ganey's Human Experience platform to pioneer advancements across the continuum of care. Ardent’s relationship with Press Ganey underscores their shared vision for a safer, more human-focused era of healthcare. Through this collaboration, Ardent will harness Press Ganey's industry-leading Human Experience platform, fostering a proactive and holistic approach to healthcare excellence and innovation. “Ardent’s partnership with Press Ganey aligns with our commitment to caring for others and a culture of safety through our MissionZERO initiative,” said Marty Bonick, President and CEO of Ardent. “As part of our journey to become a highly reliable organization, we hold ourselves to the highest standard of patient care and recognize Press Ganey as a true partner in this endeavor. Together, we understand that the people we serve are at the center of all we do. That is the Human Experience." Press Ganey's approach to patient experience and safety aligns seamlessly with Ardent's commitment to innovation and its MissionZERO imperative. Through the partnership, both organizations will push the envelope of healthcare transformation, leading the charge toward a future marked by exceptional patient outcomes and a culture of high reliability. "We are honored to stand side by side with Ardent in their unwavering resolve to achieve MissionZERO. Our mutual dedication to advancing the Human Experience in healthcare is a powerful catalyst for positive transformation," said Patrick T. Ryan, Chairman and CEO of Press Ganey. "This partnership reinforces our firm belief that every patient deserves the highest level of care and safety, and an experience defined by compassion." About Press Ganey Press Ganey, the leading Human Experience (HX) healthcare performance improvement company, offers an integrated suite of solutions that address safety, clinical excellence, patient and member experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality, and experience of care. Press Ganey is a PG Forsta company. About PG Forsta PG Forsta provides the technology and expertise to help organizations get a deeper, more complete understanding of the experiences of their audiences. The company powers the HX (Human Experience) Platform—a comprehensive experience and research technology platform that breaks down the silos between CX (Customer Experience), Employee Experience (EX), Patient Experience (PX), and Market Research. PG Forsta serves a variety of industries, including healthcare, financial services, hospitality, market research, professional services, retail, and technology. About Ardent Health Services Ardent Health Services is a leading provider of healthcare in communities across the country. With a focus on consumer-friendly processes and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent owns and operates 30 hospitals and 200+ sites of care with more than 1,400 aligned providers in six states. From newly constructed healthcare facilities and expanded services to lifesaving technology and outstanding opportunities for team members, Ardent is committed to providing the resources communities need to keep high quality healthcare close to home.

Read More

More featured news